Gyre Therapeutics Inc. (GYRE) — Cash Flow Reinvestment Rate
Gyre Therapeutics Inc. (GYRE) has a Cash Flow Reinvestment Rate of 0.96x as of March 2026, reinvesting $3.06 Million (capex $178.00K plus investments $-2.88 Million) from operating cash flow of $3.18 Million. Check earnings quality score of Gyre Therapeutics Inc. to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Gyre Therapeutics Inc. Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for Gyre Therapeutics Inc. across 5 annual periods. Explore GYRE long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Gyre Therapeutics Inc. (2007–2025)
Year-by-year capital reinvestment analysis for Gyre Therapeutics Inc.. For live market cap and broader valuation context, see Gyre Therapeutics Inc. market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.58x | $2.61 Million | $1.01 Million | $1.19 Million | ▲ +136.0% |
| 2023 | 1.09x | $28.35 Million | $25.89 Million | $8.59 Million | ▼ -37.9% |
| 2022 | 1.76x | $18.81 Million | $10.68 Million | $5.00 Million | ▲ +7259.4% |
| 2010 | 0.02x | $3.31 Million | $138.30 Million | $3.31 Million | ▼ -88.0% |
| 2007 | 0.20x | $4.94 Million | $24.84 Million | $4.94 Million | — |